Andere Sprachen Zhongsheng Group Holdings Limited

Aktien

A1CSJX

KYG9894K1085

881

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:22 10.05.2024			% 5 Tage	% 1. Jan.
15,02 ^HKD	-1,31 %		-3,72 %	-19,59 %

11.04.	Inflationsberichte aus Peking und Washington lassen asiatische Aktienmärkte abstumpfen	MT
28.03.	Ausblick auf Peking, Ex-Dividenden-Termine beunruhigen asiatische Aktienmärkte	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Borse Cina : chiudono miste con rallentamento della manifattura	30.04.
Renaissance Asia Silk Road Raises Over HK$22 Million from Share Issue	22.04.
Beijing, Washington Inflation Reports Blunt Asian Stock Markets	11.04.
Beijing Outlook, Ex-Dividend Dates Roil Asian Stock Markets	28.03.
Zhongsheng Group's 2023 Profit Falls on Lower Revenue; New CFO Named	27.03.
Zhongsheng Group Holdings Limited Appoints Yu Ning as Chief Financial Officer	27.03.
Zhongsheng Group Holdings Limited Announces Appointment of Executive Directors	27.03.
Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024	27.03.
Zhongsheng Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
Tech Sector, Earnings, Wall Street Cues Churn Asian Stock Marlets	26.03.
Zhongsheng Pharma's Chairman to Raise Stake in Company	11.03.
Zhongsheng Group Holdings Limited(SEHK:881) dropped from Hang Seng China Enterprises Index	01.03.
US Tech Outlook Boost Asian Stock Markets	22.02.
Renaissance Asia Silk Road to Issue 800 Million Shares; Shares Tank 9%	31.01.
Zhongsheng Pharma's Unit Gets Nod to Market Mirabegron	18.01.
Henan Jinyuan Hydrogenated Chemicals Launches Up to HK$358 Million Hong Kong IPO Following Spin-Off from Parent	12.12.
Zhongsheng Pharma Chairman Plans Boosting Stake	08.12.
Manufacturing Outlook Limits Asian Stock Markets	01.12.
Tiantan Biological Products Secures Another Blood Collection License	02.11.
Zhongsheng Pharmaceutical Gets Drug Registration Certificate for Carbocysteine Oral Solution	18.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zhongsheng Group Holdings Limited

Aktien

A1CSJX

KYG9894K1085

881

Andere Sprachen

Filter